Cambridge Advisors’s Clorox CLX Stock Holding History

Cambridge Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,810	Closed	-$223K	–	179
2025 Q3	$223K	Sell	1,810 -50	-3%	-$6.21K	0.04%	167
2025 Q2	$223K	Hold	1,860	–	–	0.05%	165
2025 Q1	$274K	Hold	1,860	–	–	0.06%	152
2024 Q4	$302K	Hold	1,860	–	–	0.07%	140
2024 Q3	$303K	Hold	1,860	–	–	0.07%	143
2024 Q2	$254K	Hold	1,860	–	–	0.06%	154
2024 Q1	$285K	Hold	1,860	–	–	0.07%	148
2023 Q4	$265K	Hold	1,860	–	–	0.07%	146
2023 Q3	$244K	Hold	1,860	–	–	0.07%	147
2023 Q2	$296K	Hold	1,860	–	–	0.08%	138
2023 Q1	$294K	Hold	1,860	–	–	0.08%	150
2022 Q4	$261K	Hold	1,860	–	–	0.07%	155
2022 Q3	$239K	Hold	1,860	–	–	0.07%	153
2022 Q2	$262K	Hold	1,860	–	–	0.07%	152
2022 Q1	$259K	Hold	1,860	–	–	0.06%	161
2021 Q4	$324K	Hold	1,860	–	–	0.07%	152
2021 Q3	$308K	Hold	1,860	–	–	0.08%	152
2021 Q2	$335K	Hold	1,860	–	–	0.08%	145
2021 Q1	$359K	Hold	1,860	–	–	0.09%	131
2020 Q4	$376K	Sell	1,860 -10	-0.5%	-$2.07K	0.1%	118
2020 Q3	$393K	Sell	1,870 -1	-0.1%	-$223	0.12%	104
2020 Q2	$410K	Buy	1,871 +11	+0.6%	+$2.2K	0.13%	100
2020 Q1	$322K	Sell	1,860 -40	-2%	-$6.61K	0.12%	108
2019 Q4	$292K	Sell	1,900 -104	-5%	-$15.5K	0.09%	124
2019 Q3	$304K	Hold	2,004	–	–	0.1%	106
2019 Q2	$307K	Hold	2,004	–	–	0.1%	111
2019 Q1	$322K	Hold	2,004	–	–	0.11%	109
2018 Q4	$309K	Hold	2,004	–	–	0.12%	107
2018 Q3	$301K	Hold	2,004	–	–	0.1%	115
2018 Q2	$271K	Sell	2,004 -750	-27%	-$92.6K	0.1%	116
2018 Q1	$367K	Hold	2,754	–	–	0.13%	107
2017 Q4	$410K	Hold	2,754	–	–	0.15%	98
2017 Q3	$363K	Hold	2,754	–	–	0.14%	105
2017 Q2	$367K	Sell	2,754 -300	-10%	-$40.5K	0.15%	100
2017 Q1	$412K	Sell	3,054 -100	-3%	-$13K	0.17%	93
2016 Q4	$379K	Hold	3,154	–	–	0.17%	101
2016 Q3	$395K	Hold	3,154	–	–	0.17%	96
2016 Q2	$436K	Hold	3,154	–	–	0.2%	86
2016 Q1	$398K	Hold	3,154	–	–	0.18%	91
2015 Q4	$400K	Hold	3,154	–	–	0.23%	86
2015 Q3	$364K	Hold	3,154	–	–	0.22%	90
2015 Q2	$328K	Hold	3,154	–	–	0.18%	98
2015 Q1	$348K	Hold	3,154	–	–	0.2%	92
2014 Q4	$329K	Buy	+3,154	New	+$315K	0.2%	97

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cambridge Advisors's CLX Position: Q4 2025 in Review

Cambridge Advisors sold out of Clorox (CLX) in Q4 2025, closing a stake of 1,810 shares — an estimated $223K sold.

Cambridge Advisors first reported a position in CLX in Q4 2014 and held it in 44 quarters. The position peaked at $436K in Q2 2016. 1,049 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

Cambridge Advisors reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
Cambridge Advisors sold 1,810 Clorox shares in Q4 2025, an estimated $223K.
Cambridge Advisors first reported a position in Clorox in Q4 2014 and held it in 44 quarters.
Cambridge Advisors's Clorox position peaked at $436K in Q2 2016.
1,049 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Cambridge Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.